Levels of t-tau and p-tau are increased in all parkinsonian disease groups and combining them with Aβ42 only usefully differentiates PD from frontotemporal dementia.126 Taken together, these findings suggest free blood levels of these markers are unlikely to be of diagnostic value in trials. The gene discussed is MAPT; the disease is Parkinson disease.